NCT00866918 · OUTCOME

Hematologic, Molecular, and Cytogenetic Remission Rate

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia · Source last updated 2022-10-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: Proportion of participants
Interval / dispersion: Not reported
Time frame: End of consolidation, course 3; up to 7 months (for Standard Risk) or end of consolidation, course 4; up to 9 months (for High Risk)

What was measured

Proportion of patients in hematologic, molecular, and cytogenetic remission at end of consolidation, course 3 and 4 are reported. Patients were determined to be in remission by all three criteria.

Analysis population: Patients who were ineligible (n=6), inevaluable (n=1), or who electively withdrew during Induction (n=4) were excluded.

Groups in this outcome

Standard Risk

WBC\<10,000/MicroLiter

High Risk

WBC\>=10,000/MicroLiter

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Standard Risk	63
High Risk	34

Reported measurements

Source class 1

Values in Proportion of participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Standard Risk	0.8095	Not reported	Not reported	Not reported	Not reported
High Risk	0.5882	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
0.8095
group Id
OG001
value
0.5882

denoms

counts
group Id
OG000
value
63
group Id
OG001
value
34
units
Participants

description

Proportion of patients in hematologic, molecular, and cytogenetic remission at end of consolidation, course 3 and 4 are reported. Patients were determined to be in remission by all three criteria.

groups

description
WBC\<10,000/MicroLiter
id
OG000
title
Standard Risk
description
WBC\>=10,000/MicroLiter
id
OG001
title
High Risk

param Type

NUMBER

population Description

Patients who were ineligible (n=6), inevaluable (n=1), or who electively withdrew during Induction (n=4) were excluded.

reporting Status

POSTED

time Frame

End of consolidation, course 3; up to 7 months (for Standard Risk) or end of consolidation, course 4; up to 9 months (for High Risk)

title

Hematologic, Molecular, and Cytogenetic Remission Rate

type

SECONDARY

unit Of Measure

Proportion of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice